---
layout: post
title: "Agency Information Collection Activities: Proposed Collection; Comment Request; Adverse Experience Reporting for Licensed Biological Products; and General Records"
date: 2026-02-05 18:57:00 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2023-21252
original_published: 2023-09-28 00:00:00 +0000
significance: 8.00
---

# Agency Information Collection Activities: Proposed Collection; Comment Request; Adverse Experience Reporting for Licensed Biological Products; and General Records

**Published:** February 05, 2026 18:57 UTC
**Source:** Federal Register
**Original Published:** September 28, 2023 00:00 UTC
**Document Number:** 2023-21252

## Summary

The Food and Drug Administration (FDA or Agency) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on the proposed extension of the collection of information applicable to required adverse experience reporting for licensed biological products, and general records associated with the manufacture and distribution of biological products.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2023/09/28/2023-21252/agency-information-collection-activities-proposed-collection-comment-request-adverse-experience)
- API: https://www.federalregister.gov/api/v1/documents/2023-21252

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
